Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
83.89
+22.18 (35.94%)
At close: Nov 7, 2025, 4:00 PM EST
83.88
-0.01 (-0.01%)
After-hours: Nov 7, 2025, 7:54 PM EST
Globus Medical Revenue
Globus Medical had revenue of $769.05M in the quarter ending September 30, 2025, with 22.91% growth. This brings the company's revenue in the last twelve months to $2.77B, up 11.75% year-over-year. In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth.
Revenue (ttm)
$2.77B
Revenue Growth
+11.75%
P/S Ratio
4.11
Revenue / Employee
$522,605
Employees
5,300
Market Cap
11.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
| Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
| Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
| Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
| Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GMED News
- 2 days ago - Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength. - Barrons
- 2 days ago - Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Globus Medical Reports Third Quarter 2025 Results - GlobeNewsWire
- 18 days ago - Is Wall Street Underestimating Globus Medical Stock's Potential? - Forbes
- 24 days ago - Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewsWire
- 26 days ago - Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma - GlobeNewsWire
- 2 months ago - Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc. - GlobeNewsWire
- 3 months ago - Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript - Seeking Alpha